KPV is a three-amino-acid melanocortin fragment studied for anti-inflammatory and wound-related effects. Most evidence remains preclinical; here is what PCAC’s 2026 recommendation does and does not mean.

BPC-157 is widely promoted for injury recovery and gastrointestinal health, but most published evidence is preclinical. Here is what the research, FDA review and July 2026 PCAC recommendation actually mean.

The FDA’s advisory committee recommended six peptides for possible inclusion on the 503A Bulks List—but that did not make them FDA approved or immediately legal to compound. Here is the complete guide on how we got here and what happens next.

No two patients’ skin responds the same way. A pharmacist explains how compounded dermatology combines actives like tretinoin, azelaic acid, hydroquinone, kojic acid and tranexamic acid into one custom formula for acne, melasma, aging skin, and rosacea.

“Longevity medicine” spans rapamycin, NAD+, sermorelin, GHK-Cu, methylene blue and more. A pharmacist gives the honest version — the promise and the caveats — of what compounded longevity compounds can and can’t do.

Compounded men’s health goes beyond the standard pill. A pharmacist explains custom options for low testosterone, erectile dysfunction, and libido — troches, apomorphine, oxytocin, papaverine injection therapy, and PT-141.

Genitourinary syndrome of menopause (GSM) causes vaginal dryness, irritation, and painful sex. A pharmacist explains compounded vaginal estrogen (estradiol, estriol) and DHEA — how they work locally, and what the evidence shows.

Bioidentical hormone therapy (BHRT) uses hormones identical to the ones your body makes — estradiol, estriol, progesterone, and sometimes testosterone. A pharmacist explains what compounded BHRT is, how it’s personalized for menopause symptoms, and what the evidence really says.